Dakota Gold (DC) director Alice Schroeder exercises 9,018 warrants into shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Dakota Gold Corp. director Alice D. Schroeder exercised stock warrants and increased her direct common share holdings. On March 13, 2026, she exercised 9,018 warrants at an exercise price of $2.08 per share, converting them into 9,018 shares of common stock.
After this in-the-money derivative exercise, Schroeder directly owned 345,370 shares of Dakota Gold common stock. The exercised warrant position was reduced to zero, and the filing shows no open-market purchases or sales, only the option-style conversion of warrants into common shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
9,018 shares exercised/converted
Mixed
2 txns
Insider
SCHROEDER ALICE D.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| X | WARRANTS | 9,018 | $0.00 | -- |
| X | COMMON STOCK | 9,018 | $2.08 | $19K |
Holdings After Transaction:
WARRANTS — 0 shares (Direct);
COMMON STOCK — 345,370 shares (Direct)
Footnotes (1)
FAQ
What did Dakota Gold (DC) director Alice Schroeder report in this Form 4?
Alice D. Schroeder reported exercising warrants for 9,018 shares of Dakota Gold common stock. The in-the-money derivative exercise converted warrants into shares at $2.08 per share, increasing her direct equity ownership without any open-market buying or selling activity.
What type of securities did Alice Schroeder exercise to obtain Dakota Gold common stock?
She exercised warrants, which are derivative securities giving the right to buy stock at a set price. The filing reports exercising 9,018 warrants with a $2.08 per share exercise price, resulting in the issuance of 9,018 Dakota Gold common shares to her direct ownership.
Is this Dakota Gold Form 4 transaction a routine warrant exercise or a market trade?
The transaction reflects a routine in-the-money derivative exercise, not a market trade. Alice D. Schroeder converted 9,018 warrants into 9,018 common shares at a fixed $2.08 exercise price, with no separate open-market buying or selling reported in the filing.